| Dr Kirk Eric Hilborn, DC | |
|
42950 Schoenherr, Sterling Heights, MI 48313 | |
| (586) 247-0100 | |
| (586) 247-1350 |
| Full Name | Dr Kirk Eric Hilborn |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 24 Years |
| Location | 42950 Schoenherr, Sterling Heights, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194893792 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | KH008142 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Chiropractic Health Center Pc | 9436222338 | 2 |
News Archive
Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 million in awards from the NIH for 25 separate research grants - a 20.4 percent increase in funding compared to 2011.
Black children were one-third more likely than white children to be hospitalized for a ruptured appendix in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.
› Verified 1 days ago
| Provider Name | Advanced Chiropractic Health Center Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003077470 PECOS PAC ID: 9436222338 Enrollment ID: O20080725000407 |
News Archive
Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 million in awards from the NIH for 25 separate research grants - a 20.4 percent increase in funding compared to 2011.
Black children were one-third more likely than white children to be hospitalized for a ruptured appendix in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kirk Eric Hilborn, DC 42950 Schoenherr, Sterling Heights, MI 48313 Ph: (586) 247-0100 | Dr Kirk Eric Hilborn, DC 42950 Schoenherr, Sterling Heights, MI 48313 Ph: (586) 247-0100 |
News Archive
Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 million in awards from the NIH for 25 separate research grants - a 20.4 percent increase in funding compared to 2011.
Black children were one-third more likely than white children to be hospitalized for a ruptured appendix in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.
› Verified 1 days ago
Schwalm Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 43401 Schoenherr Rd, Sterling Heights, MI 48313 Phone: 586-726-7777 | |
Mackenzie Kate Goss, Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 5600 Metropolitan Pkwy, Sterling Heights, MI 48310 Phone: 586-264-2100 Fax: 586-264-1117 | |
Brian J. Gennero D.c. P.l.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 14445 15 Mile Rd, Sterling Heights, MI 48312 Phone: 586-268-6868 | |
Dr. Derek L Bittner, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 13927 Plumbrook, 200, Sterling Heights, MI 48312 Phone: 586-978-8088 Fax: 586-978-8085 | |
Greatlakes Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4105 Metro Pkwy Ste 101, Sterling Heights, MI 48310 Phone: 586-939-1003 Fax: 586-939-3862 | |
Operation Wellness Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8200 Irving Rd, Sterling Heights, MI 48312 Phone: 313-801-4444 | |
Dr. Ryan N Bittner, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 37316 Schoenherr Rd, Sterling Heights, MI 48312 Phone: 586-978-8008 Fax: 586-978-8085 |